Where does Jaume Pons work?

Jaume Pons is Venture Partner at venBio Partners.

What does Jaume Pons invest in?

Jaume Pons invests in Biotech, Healthtech.

What check size does Jaume Pons write?

Jaume Pons typically writes checks of $20M – $30M.

What boards does Jaume Pons sit on?

Jaume Pons holds tracked board seats at Alexo Therapeutics, Tallac Therapeutics.

Where did Jaume Pons go to school?

Jaume Pons studied at University of California, Berkeley (Postdoc, Protein Engineering); Universitat de Barcelona.

Jaume Pons

Investor

Venture Partner at venBio Partners

Burlingame, California

Writes $20M – $30M checks · typically $25M

About

Jaume Pons personally invented Ajovy (an anti‑CGRP antibody commercialized by Teva), led 13 protein therapeutics into human trials, and co‑founded ALX Oncology, taking it from inception through IPO.

Invests in

BiotechHealthtech

Experience

venBioVenbio Venture partnercurrent2015 — presentUnited States
ALX OncologyPresident and CSO2023 — 2025San Francisco Bay Area
ALX OncologyPresident and CEO2015 — 2023Burlingame, CA
ALX OncologyPresident and CEO2015 — 2023Burlingame, CA
Rinat (Pfizer)Pfizer SVP and Rinat CSO2009 — 2015South San Francisco. CA
Rinat (Pfizer)VP and Rinat CSO2008 — 2009
Rinat (Pfizer)Chief Scientific Officer, Rinat2007 — 2009
ChironScientist 21999 — 2002
UC BerkeleyPosdoc (Kirsch lab)1996 — 1999

Skills & more

Biotechnology38Drug Development21Drug Discovery31Lifesciences9Clinical Development8Biopharmaceuticals8Protein Chemistry13Technology Transfer5Biochemistry4R&D6Immunology9Life Sciences14

+5 more

Pharmaceutical IndustryAssay DevelopmentMolecular BiologyOncologyMonoclonal Antibodies

From Jaume's professional profile.

Deals · 1

Alexo TherapeuticsBoard seat

via venBio Partners · filed May 2015 · $36M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Tallac Therapeutics

Per SEC Form D filings.

Colleagues at venBio Partners

Aaron Royston

Managing Partner at venBio Partners

Corey Goodman

Co-founder and Managing Partner at venBio Partners

Daniel Teichmann

Controller at venBio Partners

David Pezeshki

Chief Financial Officer at venBio Partners

Parthiv Patel

Analyst at venBio Partners

Richard Gaster

Managing Partner at venBio Partners

Yvonne Yamanaka

Partner at venBio Partners

Network2

Aaron Royston

Managing Partner at venBio Partners

Corey Goodman

Co-founder and Managing Partner at venBio Partners

Investors connected to Jaume in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jaume Pons?: Jaume Pons personally invented Ajovy (an anti‑CGRP antibody commercialized by Teva), led 13 protein therapeutics into human trials, and co‑founded ALX Oncology, taking it from inception through IPO.
Where does Jaume Pons work?: Jaume Pons is Venture Partner at venBio Partners.
What does Jaume Pons invest in?: Jaume Pons invests in Biotech, Healthtech.
What check size does Jaume Pons write?: Jaume Pons typically writes checks of $20M – $30M.
What boards does Jaume Pons sit on?: Jaume Pons holds tracked board seats at Alexo Therapeutics, Tallac Therapeutics.
Where did Jaume Pons go to school?: Jaume Pons studied at University of California, Berkeley (Postdoc, Protein Engineering); Universitat de Barcelona.